Inflammation in Vascular Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorGöteborg University
About this trial
Increasing evidence suggests that systemic low-grade inflammation may be a driving force of cardiometabolic complications, such as vascular dysfunction, atherosclerosis and ischemic heart disease. Thus, we will investigate the role of inflammation in cardiovascular disease.
Eligibility criteria
Qualifiers
Patient is planned to undergo vascular surgery.
Signed informed consent has been obtained from the patient.
Disqualifiers
Patient has difficulty to understand information.
Patients under 18 years of age.
Patients participating in any drug-related study.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
170 Participants
are grouped into 2 trial groupsSponsors and collaborators
Source ClinicalTrials.gov